| 1. |
Czerkinsky C. C., Nilsson L. A., Nygren H., Ouchterlony O., and Tarkowski A. (1983) A solid-phase enzyme-linked immunospot
(ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods
16, 109–121.
|
| |
| 2. |
Czerkinsky C., Andersson G., Ekre H. P., Nilsson L. A., Klareskog L., and Ouchterlony O. (1988) Reverse ELISPOT assay for
clonal analysis of cytokine production: I. Enumeration of gamma-interferon-secreting cells. J. Immunol. Methods
110, 29–36.
|
| |
| 3. |
Tanguay S., and Killion J. J. (1994) Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting
cells. Lymphokine Cytokine Res.
13, 259–263.
|
| |
| 4. |
Carter L. L., and Swain S. L. (1997) Single cell analyses of cytokine production. Curr. Opin. Immunol.
2, 177–182.
|
| |
| 5. |
Altman J. D., Moss P. A. H., Goulder P. J. R., Barouch D. H., McHeyzer-Williams M. G., Bell J. I., et al. (1996) Phenotypic
analysis of antigen-specific T-lymphocytes. Science
274, 94–96.
|
| |
| 6. |
Sarawar S. R., and Doherty P. C. (1994) Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the
regional lymph nodes of mice with influenza pneumonia. J. Virol.
68, 3112–3119.
|
| |
| 7. |
Mo X. Y., Sarawar S. R., and Doherty P. C. (1995) Induction of cytokines in mice with parainfluenza pneumonia. J. Virol.
69, 1288–1291.
|
| |
| 8. |
Murata K., Garcia-Sastre A., Tsuji M., Rodrigues M., Rodriguez D., Rodriguez J. R., et al. (1996) Characterization of in vivo primary and secondary CD8+ T-cell responses induced by recombinant influenza and vaccinia viruses. Cell. Immunol.
173, 96–107.
|
| |
| 9. |
Murali-Krishna K., Altman J. D., Suresh M., Sourdive D. J., Zajac A. J., Miller J. D., et al. (1998) Counting antigen-specific
CD8 T-cells: a reevaluation of bystander activation during viral infection. Immunity
8, 177–187.
|
| |
| 10. |
Oliveira-Ferreira J., Miyahira Y., Layton G. T., Savage N., Esteban M., Rodriguez D., et al. (2000) Immunogenicity of Ty-VLP
bearing a CD8+ T-cell epi-tope of the CS protein of P. yoelii enhanced memory response by boosting with recombinant vaccinia virus. Vaccine
18, 1863–1869.
|
| |
| 11. |
Tobery T. W., Wang S., Wang X. M., Neeper M.P, Jansen K. U., McClements W. L., and Caulfield M. J. (2001) A simple and efficient
method for the monitoring of antigen-specific T-cell responses using peptide pool arrays in a modified ELISpot assay. J Immunol. Methods
254, 59–66.
|
| |
| 12. |
Maecker B., Sherr D. H., Vonderheide R. H., von Bergwelt-Baildon M. S., Hirano N., Anderson K. S., et al. (2003) The shared
tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T-cells. Blood
102, 3287–3294.
|
| |
| 13. |
Whitton J. L., Tishon A., Lewicki H., Gebhard J., Cook T., Salvato M., et al. (1989) Molecular analyses of a five-amino-acid
cytotoxic T-lymphocyte (CTL) epi-tope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J. Virol.
63, 4303–4310.
|
| |
| 14. |
Schulz M., Aichele P., Schneider R., Hansen T. H., Zinkernagel R. M., and Hengartner H. (1989) Major histocompatibility complex
binding and T-cell recognition of a viral nonapeptide containing a minimal tetrapeptide. Eur. J. Immunol.
21, 1181-185.
|
| |
| 15. |
Galvin M. A., Gilbert M. J., Riddell S. R., Greenberg P. D., and Bevan M. J. (1993) Alkali hydrolysis of recombinant proteins
allows for the rapid identification of class I MHC-restricted CTL epitopes. J. Immunol.
151, 3971–3980.
|
| |
| 16. |
Vitiello A., Ishioka G, Grey H. M., Rose R., Farness P., LaFond R., et al. (1995) Development of a lipopeptide-based therapeutic
vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T-lymphocyte response in humans. J. Clin.Invest.
95, 341–349.
|
| |
| 17. |
van der Most R. G., Sette A., Oseroff C., Alexander J., Murali-Krishna K., Lau L. L., et al. (1996) Analysis of cytotoxic
T-cell responses to dominant and sub-dominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
J. Immunol.
157, 5543–5554.
|
| |
| 18. |
Kalyuzhny A., and Stark S. (2001) A simple method to reduce the background and improve well-to-well reproducibility of staining
in ELISPOT assays. J. Immunol. Methods
257, 93–97.
|
| |
| 19. |
Power C. A., Grand C. L., Ismail N., Peters N. C., Yurkowski D. P., and Bretscher P. A. (1999) A valid ELISPOT assay for enumeration
of ex vivo, antigen-specific, IFN gamma-producing T-cells. J. Immunol. Methods
227, 99–107.
|
| |
| 20. |
Miyahira Y., Murata K., Rodriguez D., Rodriguez J. R., Esteban M., Rodrigues M. M., et al. (1995) Quantification of antigen
specific CD8+ T-cells using an ELISPOT assay. J. Immunol. Methods
181, 45–54.
|
| |
| 21. |
Carvalho L. H., Hafalla J. C., and Zavala F. (2001) ELISPOT assay to measure antigen-specific murine CD8+ T-cell responses. J. Immunol. Methods
252, 207–218.
|
| |
| 22. |
Slifka M. K., Rodriguez F., and Whitton J. L. (1999) Rapid on/off cycling of cytokine production by virus-specific CD8+ T-cells. Nature
401, 76–79.
|
| |
| 23. |
Currier J. R., Kuta E. G., Turk E., Earhart L. B., Loomis-Price L., Janetzki S., et al. (2002) A panel of MHC class I restricted
viral peptides for use as a quality control for vaccine trial ELISPOT assays. J. Immunol Methods
260, 157–172.
|
| |